Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2003-09-15
2009-10-20
Wilson, James O (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
active
07605259
ABSTRACT:
A family of structurally rigid dopamine D3 receptor selective ligands is described. The family of structurally rigid dopamine D3 receptor selective ligands has the formula wherein A is cis or trans —CH═CH—, —C═C—, or cyclohexyl. B is cis or trans —CH═CH— or absent. R1 represents an optionally substituted phenyl group, wherein said substituents are selected from the group consisting of: hydrogen, halogen, amino, nitro, hydroxyl, alkoxy, alkyl, acyl and pyridyl, and said substitution may occur at any of the ortho, meta, or para positions, or R1 represents a heteroaromatic ring. A preferred heteroaromatic ring is indole, quinoxoline, pyridyl, pyrimidyl, or imidazole. R2 and R3 may be independently hydrogen or a halogen, or R2 alone may be C1, C2, or C3 alkoxy, and m is 1 or 2, and n is 0, 1, or 2.
REFERENCES:
patent: 5143923 (1992-09-01), Hrib et al.
patent: 5958923 (1999-09-01), Hellendahl et al.
patent: 6124294 (2000-09-01), Hellendahl et al.
patent: 6342604 (2002-01-01), Hellendahl et al.
patent: 4 425 143 (1996-01-01), None
patent: 4 425 144 (1996-01-01), None
patent: 4 425 145 (1996-01-01), None
patent: WO2001096323 (2001-12-01), None
Newman et al. Bioorganic and Medicinal Chemistry Letters, 2003, 13, 2179-83.
PiIla, M. et al. Nature 400 371-375 (1999).
DiCiano, P. et al. Neuropsychopharmacology 28 329-338 (2003).
Yokoi F. et al., Neuropsychopharmacology 27 (2) 248-259 (2002).
Soares JC and Innis RB, Society of Biol Psychiatry 46(5) 600-615 (1999).
Huang et al. J. Med. Chem 44 1815-1826 (2001).
Luedtke et al. Synapse 38 438-449 (2000).
Videbaek C, J Cereb Blood Flow Metab 21 92-97 (2000).
Pilowsky L.S., Nucl Med Commun 22; 829-833 (2001).
Langer, Science 249 1527-1533 (1990).
Vorel, S.R. et al. J Neurosci 22 9595-9603 (2002).
Joyce, Pharmacol & Therapeutics 90 (2-3) 231-259 (2001).
Le Foll et al., Eur J Psychiatry vol. 15 140-146 (2000).
Grundt Peter
Luedtke Robert R.
Newman Amy
Cantor & Colburn LLP
Jarrell Noble
University of North Texas Health Science Center at Fort Worth
Wilson James O
LandOfFree
Structurally rigid dopamine d3 receptor selective ligands... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Structurally rigid dopamine d3 receptor selective ligands..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Structurally rigid dopamine d3 receptor selective ligands... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4052532